Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Weak
Earnings
Very Strong
Earnings
Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Protara Therapeutics, Inc.
Telephone
1.646.844.0337
Address
3rd Floor, 345 Park Avenue South, New York, NY 10010
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 2.77 - 7.82
Trade Value (12mth)
US$898,921.00
1 week
-14.9%
1 month
-18.42%
YTD
-19.33%
1 year
33.54%
All time high
800.00
EPS 3 yr Growth
-77.10%
EBITDA Margin
0.00%
Operating Cashflow
-$56m
Free Cash Flow Return
-30.50%
ROIC
-31.10%
Interest Coverage
0.00
Quick Ratio
14.60
Shares Outstanding (Fully Diluted)
58m
HALO Sector
Healthcare
Next Company Report Date
10-Mar-27
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
USD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 13 May 26 | |
| 13 May 26 | |
| 13 May 26 | |
| 30 March 26 | |
| 10 March 26 |
Historical data
Forecast data
| USD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -3.57 | -2.17 | -1.34 | | | | ||
EPS (Fully Diluted) | $ | | | | | -3.57 | -2.17 | -1.34 | | | | ||
Growth | % | | | | | 39.1 | 39.3 | 38.1 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
